Stock Taper
SCREENER COMPARE ANY 2 STOCKS
GRAL
GRAIL INC.
NASDAQ
$80.00
▼ DOWN 3.03% (-2.50)

KEY STATISTICS

Market Cap$3.43 B
52w High$118.84
52w Low$30.82
Dividend Yield—
Frequency—
P/E-8.21
Volume658.44K
Shares Out.42.92M

COMPANY

LEADERSHIP

Joshua J. Ofman
CHIEF EXECUTIVE
Joshua J. Ofman

COMPENSATION 2026

Salary$785,000
Stock Awards$6,478,041
Incentive Plan Pay$778,092
All Other Comp.$53,307
Total$8,094,440

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 12, 2024
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
910

PRICE TARGET

Target High$70.00
Target Low$56.00
Target Median$62.50
Target Consensus$62.75

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.$44.32M
NOV
11
WED

PRICE

$80.00 ▼ DOWN 3.03% (−$2.50)
$78.75$79.50$80.25$81.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM80.00

About GRAIL Inc.

http://www.grail.com ↗

GRAIL, Inc. is a Menlo Park-based biotech company developing early cancer detection tests like Galleri and DAC, focusing on improving diagnostics for asymptomatic individuals over 50 and those with suspected cancer.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT GRAIL INC. IS KNOWN FOR

Galleri
Galleri

Galleri is a multi-cancer early detection blood test that identifies over 50 cancer types from a single draw, complementing existing screenings and aiding early detection of cancers without current screening options.

COMPETITORS

COMPETITOR
BNR COMPARE
GH COMPARE
NTRA COMPARE

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$32.57M $69.98M ▲$38.73M ▼$41.45M ▲
NonUS$3.31M $1.31M ▼$1.11M ▼$1.84M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
142
LISTED HERE
26
RANKED BY POSITION SIZE
XBI
1.05% · 1.5M
VTS.AX
0.00% · 1.2M
XSU.TO
0.11% · 1.1M
SCHA
0.06% · 155.7K
FESM
0.16% · 124.6K
DFMC
0.12% · 111.4K
PRFZ
0.25% · 87.3K
PSC
0.24% · 81.3K
AVSC
0.19% · 74.0K
XMLH.DE
1.83% · 73.2K
LABU
0.71% · 55.1K
PINK
0.97% · 45.3K
XRS2.DE
0.11% · 37.0K
FYC
0.16% · 27.3K
RSSL
0.11% · 19.7K
HTEC
1.83% · 17.4K
BBSC
0.12% · 11.0K
GSSC
0.08% · 10.5K
HELX
1.21% · 4.8K
SGRW
1.03% · 3.7K
URTY
0.04% · 1.7K
STXK
0.13% · 1.4K
RFLR
0.10% · 1.1K
ESSC
0.18% · 952
VETS
0.15% · 847
USFMDN.MX
0.01% · 186

INSTITUTIONAL OWNERSHIP

SHARES OWNED
65.10%
HOLDERS
514
TOP 12 OF 514 · RANKED BY POSITION SIZE
Farallon Capital Management LLC
4.2M sh · $284.11M
Baker Bros. Advisors LP
4.0M sh · $275.03M
Blackrock, Inc.
3.6M sh · $244.21M
State Street Corp
2.4M sh · $162.86M
Primecap Management Co/Ca/
2.2M sh · $148.84M
Sessa Capital Im, L.P.
2.0M sh · $139.1M
Vanguard Group Inc
2.0M sh · $169.54M
Crcm LP
1.8M sh · $108.96M
Deep Track Capital, LP
1.8M sh · $125.27M
Morgan Stanley
1.6M sh · $84.35M
Blackrock Inc.
1.2M sh · $19.07M
Arbiter Partners Capital Management LLC
1.0M sh · $61.25M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

★
DIRECTOR
MIZELL STEVEN
Purchase · 268 shares
2026-07-15
★
DIRECTOR
CHASE WILLIAM J
Purchase · 276 shares
2026-07-15
★
DIRECTOR
SUMME GREGORY L
Purchase · 427 shares
2026-07-15
★
DIRECTOR
SUMME GREGORY L
Purchase · 5.5K shares
2026-06-18

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
NEUTRAL 2
EQUAL WEIGHT 1
OUTPERFORM 1
7 GRADES IN THE LAST 12 MONTHS
Mizuho NEUTRAL Piper Sandler NEUTRAL TD Cowen BUY Guggenheim BUY Morgan Stanley EQUAL WEIGHT Canaccord Genuity BUY Baird OUTPERFORM

SECTORS PEERS

PEERPRICE
APGE$134.97COMPARE
XENE$59.99COMPARE
DYN$25.07COMPARE
NVST$27.13COMPARE
CELC$88.44COMPARE
IDYA$40.11COMPARE
RARE$25.61COMPARE
AAPG$18.28COMPARE